Asthma in pregnancy

American Journal of Medicine

Volumn 109, Issue 9, 2000, Pages 727-733

  Tan, Kia Soong ^a   Thomson, Neil C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOPHYLLINE; ANTIHISTAMINIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHLORPHENIRAMINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; ORCIPRENALINE; PHENYLEPHRINE; PREDNISOLONE; PREDNISONE; PSEUDOEPHEDRINE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE;

ASTHMA; CESAREAN SECTION; CONGENITAL MALFORMATION; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS HYPOXIA; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; MATERNAL TREATMENT; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERIUM; RESPIRATORY TRACT INFLAMMATION; REVIEW; TREATMENT PLANNING; UTERUS BLEEDING;

ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; DECISION TREES; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERTENSION; INFANT; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; STEROIDS; THEOPHYLLINE; UTERINE HEMORRHAGE;

EID: 0034671577     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00615-X     Document Type: Review

References (70)

1. Medical problems during pregnancy
2. Management of asthma during pregnancy
3. Asthma during pregnancy: Current concepts
4. The course and outcome of pregnancy in women with bronchial asthma
5. Perinatal outcomes in women with asthma during pregnancy
6. Infant and maternal outcomes in the pregnancies of asthmatic women
7. Association between pregnancy-induced hypertension and asthma during pregnancy
8. Asthma and pregnancy: A prospective study of 198 pregnancies
9. Severity of asthma and perinatal outcome
10. Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome
11. Acute asthma during pregnancy
12. Perinatal outcomes in the pregnancies of asthmatic women: A prospective controlled analysis
13. Fetal morbidity following potentially anoxigenic obstetric conditions. VII. Bronchial asthma
14. Outcome of pregnancy in women requiring corticosteroids for severe asthma
15. Clinical aspects of placental gas exchange
16. Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women
17. Corticosteroid therapy for the pregnant asthmatic patient
18. Outcomes of pregnancy in adolescents with severe asthma
19. The effects of pregnancy on asthma: A prospective study
20. A prospective study of asthma during pregnancy and the puerperium
21. The course of asthma during pregnancy, post partum, and with successive pregnancies: A prospective analysis
22. Lung function tests in bronchial asthma during and after pregnancy
23. Improvement in airway responsiveness and asthma severity during pregnancy. A prospective study
24. Gap junction formation in the myometrium: Control by estrogens, progesterone, and prostaglandins
25. Asthma variation with menstruation
26. Premenstrual exacerbation of asthma
27. Morbidity in asthma in relation to the menstrual cycle
28. Absence of changes in airway responsiveness during the menstrual cycle
29. Airway responsiveness to methacholine during the natural menstrual cycle and the effect of oral contraceptives
30. Influence of the menstrual cycle on airway function in asthmatic and normal subjects
31. Pulmonary function and bronchial hyperresponsiveness in various phases of the menstrual cycle
32. 2-adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients
33. 2-adrenoceptors during the menstrual cycle
34. 2-adrenoceptors in normal females
35. 2-adrenoceptors by exogenous progesterone in female asthmatics
36. 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients
37. In vivo quantification of human pulmonary β-adrenoceptors: Effect of β-agonist therapy
38. Effect of sex of fetus on asthma during pregnancy: Blind prospective study
39. Use of asthma drugs is less among women pregnant with boys rather than girls
40. Modulation of airway reactivity and diurnal peak flow variability in asthmatics receiving the oral contraceptive pill
41. Influence of the menstrual cycle on skin-prick test reactions to histamine, morphine and allergen
42. Increased nitric oxide in exhaled air of asthmatic patients
43. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients
44. Spontaneous and induced sputum to measure indices of airway inflammation in asthma
45. Peak expiratory nitric oxide differences in men and women: Relation to the menstrual cycle
46. Asthma during pregnancy: Interrelationships and management
47. 1995 review and position statement
48. Risk of congenital malformations associated with treatment of asthma during pregnancy
49. The American College of Allergy, Asthma, and Immunology Registry for Allergic, Asthmatic Pregnant Patients (RAAPP)
50. Maternal-fetal medicine units studies of inhaled corticosteroid during pregnancy
51. The safety of inhaled β-agonist bronchodilators during pregnancy
52. The safety of asthma and allergy medications during pregnancy
53. Pulmonary oedema associated with ritodrine infusion and betamethasone administration in premature labour
54. Asthma in pregnancy complicated by iatrogenic pulmonary oedema
55. Inhaled glucocorticoids for asthma
56. Asthma treatment in pregnancy: A randomised controlled study
57. Cortisol induced congenital cleft palate in rabbits
58. Beclomethasone dipropionate for severe asthma during pregnancy
59. Congenital malformations after the use of inhaled budesonide in early pregnancy
60. Corticosteroids during pregnancy and oral clefts: A case control study
61. Perinatal exposure to prednisone in humans and animals retards intrauterine growth
62. Acute asthma among pregnant women presenting to the emergency department
63. Theophylline clearance during pregnancy
64. Slow-release theophylline in pregnant asthmatics
65. Incidence of preeclampsia among asthmatic patients lower with theophylline
66. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
67. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
68. Effect of inhaled formoterol and budesonide on exarcebations of asthma